Major genetic drivers of melanoma oncogenesis are the gain-of-function mutations of B-Raf (BRAF), neurofibromin 1 (NF1), and NRAS, which contribute to the activation of the ERK/MAPK pathway, resulting in the uncontrolled growth, proliferation, and enhanced survival of tumor cells [1]. Here, BRAF is linked to neoplasm.